Independently tested/Batch-level documentation
CJC-1295 No DAC/Ipamorelin illustrative clear glass vial with Lana Peptides label

Illustrative image. Catalogue strength: 5 mg / 5 mg; image label may differ.

CJC-1295 No DAC/Ipamorelin

Research MaterialSample Results Published

A blended reference material containing CJC-1295 (modified GRF 1-29) and Ipamorelin, supplied for in-vitro laboratory research.

Material
CJC-1295 No DAC/Ipamorelin
Form
Lyophilized powder
Vial quantity
5 mg / 5 mg · 1 vial
Batch number
BLD-501
Testing status
Report published
Storage
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Provisional retail price · CAD$75.00
Price$75.00
1

Supplied for laboratory research use only. Not for human or veterinary use.

Verification

Latest Test Results

Batch: BLD-501

Identity
Reported components: CJC-1295 No DAC and Ipamorelin (HPLC-MS/MS).
Quantity
CJC-1295: 5.78 mg; Ipamorelin: 6.25 mg; laboratory-reported total net content: 12.04 mg (tested sample).
Purity
CJC-1295: 99.85%; Ipamorelin: 99.89% chromatographic purity (tested sample).
Additional testing
No endotoxin or sterility results supplied.
Independent laboratory
Peptide Test Canada / Side-Chain Analytics Inc.
Testing date
November 5, 2026

Laboratory sample ID BLD-501; report COA-2026-SC-04743; verification reference PTC-K487EXBD. Received October 29, 2026; analyzed and reported November 5, 2026. This record uses the laboratory sample ID, not a confirmed inventory lot number. Total net content is reproduced as reported by the laboratory; displayed rounded component values sum to 12.03 mg. Results apply only to the sample as received, not other vials or any entire lot or batch. They do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use. Laboratory permission to display the full report was confirmed by the owner.

Batch archive

Material Overview

CJC-1295 / Ipamorelin is supplied as a blended peptide reference material. CJC-1295 (without DAC) is a modified growth hormone-releasing factor analogue; Ipamorelin is a synthetic pentapeptide studied as a growth hormone secretagogue receptor ligand. Each batch is submitted for independent analytical testing.

Research Context

Both molecules have been studied in the published literature in relation to growth hormone axis signalling in laboratory and animal models. Research findings do not constitute clinical evidence of efficacy in humans.

Storage & Handling

Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.

Molecular Information

Peptide sequence
Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular formula
CJC-1295: C152H252N44O42 · Ipamorelin: C38H49N9O5
Molecular weight
CJC-1295: 3367.9 g/mol · Ipamorelin: 711.85 g/mol
CAS number
863288-34-0 (CJC-1295) · 170851-70-4 (Ipamorelin)
Synonyms
Modified GRF (1-29); NNC 26-0161
Research classification
Peptide blend reference material

Common questions about CJC-1295 No DAC/Ipamorelin

What purity is CJC-1295 No DAC/Ipamorelin tested to?
Our specification is Reported per batch. Each lot's sample is sent to an independent third-party laboratory, and published reports apply only to the sample tested.
How should CJC-1295 No DAC/Ipamorelin be stored?
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
What strength and form is supplied?
5 mg / 5 mg per vial, supplied as lyophilized powder.
Where does CJC-1295 No DAC/Ipamorelin ship from?
Orders are processed and dispatched within Canada. Shipping is $22 CAD on orders under $300 and free at $300 or more.
Is CJC-1295 No DAC/Ipamorelin for human use?
No. It is sold strictly for laboratory research use only and is not for human or veterinary consumption.
CJC-1295 No DAC/Ipamorelin
5 mg / 5 mg · $75.00 CAD
1